PEDIATRICS Vol. 85 No. 2 February 1990, pp. 235-236
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OGDEN, A. K.
Right arrow Articles by STEUBER, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OGDEN, A. K.
Right arrow Articles by STEUBER, C. P.

Bone Marrow Transplants

ANGELA KENT OGDEN MD1 and C. PHILIP STEUBER MD1

1 Division, Hematology/Oncology, Baylor College of Medicine, Texas Children's Hospital, 6621 Fannin St, Houston, TX 77030

To the Editor.—

Bone marrow transplantation has been increasingly undertaken and found effective for a variety of otherwise incurable diseases. As with all new therapies, the economic and ethical impact of the procedure requires continuing reevaluation. Durbin1 clearly stated the dilemmas faced by transplantation centers, insurance carriers, government agencies, and the public in general. Furman2 offered a limited view of transplantation and stated that bone marrow transplantation "may be neither ethical nor imperative as a therapy for dying children."